molecular radiotherapeutics

Related by string. * MOLECULAR . Molecular : molecular diagnostic assays . molecular biology . molecular mechanisms underlying . underlying molecular mechanisms / : molecular imaging radiotherapeutics . radiotherapeutics . targeted radiotherapeutic . directed radiotherapeutic antibody * lead molecular radiotherapeutic . targeted molecular radiotherapeutics *

Related by context. All words. (Click for frequent words.) 84 molecular imaging pharmaceuticals 77 targeted molecular radiotherapeutics 73 molecular imaging radiopharmaceuticals 71 targeted radiotherapeutics 66 Zemiva TM 66 rxRNA 64 adrenergic regulation 64 commercializing therapeutic 64 romazarit 64 commercializing anti infective 64 Inc. Nasdaq VIAP 64 molecular imaging radiopharmaceutical 63 Solazed TM 62 oncology therapeutics 62 targeted radiotherapeutic 62 HepDirect R 62 candidates Azedra TM 62 vaccines oncolytic virus 62 Nasdaq RGDX 62 OTC BB PVCT 62 dermatology therapies 62 Prodarsan R 62 Provectus Pharmaceuticals specializes 62 OTCBB HXBM developer 62 anti infective treatments 62 Nasdaq HALO biopharmaceutical 61 tiapamil 61 NuMimetic TM 61 neurodegenerative diseases oncology 61 AMEX REX 61 postherpetic neuralgia PHN painful 61 Pervasis 61 Adnectin 61 kidney urologic 61 Intarcia 61 novel anti infective 61 VALSTAR 61 novel therapeutic antibodies 61 acne impetigo 61 lead molecular radiotherapeutic 61 antiangiogenesis therapies 61 Ventrus 61 DPX Survivac 60 Selective Electrochemical Tumor Ablation 60 Inc. Nasdaq NEXM 60 anticancer therapeutics 60 CCR9 antagonist 60 Insegia 60 Nasdaq LXRX biopharmaceutical 60 Memory MRAM 60 Response Genetics Inc. 60 NYSE Amex PBTH 60 NYSE Amex AEN 60 novel immunotherapies 60 PI3K/Akt pathway inhibitor 60 OTCBB CHKT biotechnology 60 AzaSite Xtra 60 PNP inhibitor 60 Inc. AMEX YMI 60 BC SeraPro proteomic 60 chronic peripheral neuropathic 60 Inc. NASDAQ AEZS 60 Personalized Immunotherapy 60 Rhucin ® recombinant 60 oncolytic virus therapies 60 FOLOTYN ® 60 TRACON Pharmaceuticals 60 autologous cellular therapy 60 Friedreich Ataxia FRDA 60 OTCBB CVBT 60 immunologic diseases 59 XmAb ® 59 photodisinfection 59 LungAlert TM 59 orthobiologic 59 including eniluracil ADH 59 oral ghrelin agonist 59 CRMD pharmaceutical 59 Inc. OTCBB SPRX 59 Inc. OTCBB ALRX 59 Nasdaq MITI biopharmaceutical 59 NASDAQ EPIX 59 Combivir Kivexa 59 Azedra TM Onalta TM 59 molecular biomarkers 59 acetonide FA 59 New Chemical Entities 59 NASDAQ AVEO biopharmaceutical 59 prostone 59 carbohydrate polymers 59 OTCBB PYTO 59 muscarinic receptor agonist 59 Shrink OTCBB INKN 59 biosurgical 59 NasdaqGM SPPI commercial 59 Curaxin 59 DNA methylation biomarkers 59 ophthalmic therapeutics 59 NASDAQ AEZS TSX AEZ 59 investigational pan BCR 59 SinuNase ™ 59 mertansine 59 ulimorelin 59 immatics 59 Myocet 59 Inc. NASDAQ CRIS 59 drug GAP #B# 59 Curaxin CBLC# 59 targeting refractory relapsing 59 aptamer therapeutics 59 ASONEP TM 59 Solazed 58 immunotherapeutic approaches 58 include ColorectAlert TM 58 Aeolus Pharmaceuticals 58 Inc. NASDAQ IDMI 58 monoclonal antibody therapeutics 58 novel antiviral therapeutics 58 diagnostic molecular imaging 58 utilizes InSite Vision 58 rusalatide acetate 58 product platforms AZX# 58 MCSP respectively 58 Mesoblast Limited ASX MSB 58 OTCBB VCRT 58 Factor VIIa 58 Inc. OTCBB VODG 58 TSX YM AIM 58 NasdaqGM SPPI 58 embolotherapy 58 passive immunotherapy products 58 include Altastaph TM 58 cognitive impairment associated 58 OTCBB INSV 58 Inc. Nasdaq NLTX 58 molecular diagnostic kits 58 Tranzyme Pharma 58 oral transdermal 58 Æterna Zentaris Inc. 58 proven DuraSite ® 58 cancer immunotherapies 58 Cellgate Inc. 58 ALN PCS 58 Nasdaq IDIX biopharmaceutical 58 novel peptides 58 miRNA therapeutics 58 Adenosine Therapeutics 58 Nasdaq CGEN 58 Insmed Incorporated NASDAQ INSM 58 CVac 58 enhance ApoA 58 RECOTHROM ® 58 TSX VIR 58 Thrombin topical Recombinant 58 Trofex TM 58 Adnexus Therapeutics 58 ZEVALIN ® 58 Inc. NASDAQ SNUS 58 MKC# MKC# PP 58 commercializing aptamer therapeutics 58 NeutroSpec TM 58 treating peripheral arterial 58 sarcoma melanoma 58 Vaccinex 58 diabetes irritable bowel 58 Trofex 58 Cutanea 58 Inc. OTCBB SNWV 58 trastuzumab DM1 T DM1 58 NASDAQ BTRX pharmaceutical 58 OTCBB NVLT biopharmaceutical 58 MKC# MT 58 OTCBB IMUC 58 liposomal delivery 58 sodium thiosulfate STS 58 novel antibody therapeutics 58 trial evaluating PRX# 58 Initiates Enrollment 58 VitiGam 58 Zemiva ™ 58 MyVax ® 58 oral prodrug 58 Evoltra ® 58 therapeutic monoclonal antibodies 58 4SC AG ISIN DE# 58 immunotherapies 2A/Furin 58 UltiMAb 58 Panzem ® 58 Pentad TM 58 Phase IIb clinical trials 58 Accentia Biopharmaceuticals 58 commercialize Aganocides 58 OTC BB PVCT http:/www.pvct.com 57 therapeutic radiopharmaceuticals 57 Novosom 57 Phenomix Corporation 57 OTCBB NRGX biotechnology 57 oral JAK#/JAK# inhibitor 57 Verisante 57 myeloproliferative disorders 57 introduced NEUGENE 57 Supernus 57 theranostic 57 Nasdaq OPTR 57 MyVax R 57 Aradigm Corporation OTCBB ARDM 57 Corp. Nasdaq BSTC 57 Therinject 57 subsidiaries visit http:/www.apricusbio.com 57 OTCBB AEMD pioneer 57 personalized cellular immunotherapy 57 Frankfurt XMP 57 P#X# antagonist 57 INxin 57 Onalta 57 ImmuneRegen BioSciences Inc. 57 Adrenomyeloneuropathy AMN HIV 57 PRNewswire FirstCall YM BioSciences 57 immuno inflammatory diseases 57 immunological diseases 57 Oracea TM 57 PANVAC VF 57 Inc. Nasdaq TNGN 57 Xanthus Pharmaceuticals Inc. 57 Helinx technology 57 CollaFix TM 57 liver cancers hypercholesterolemia 57 NASDAQ IDEV 57 AcryMed Incorporated 57 colorectal bladder 57 immunotherapeutics 57 therapeutic monoclonal antibody 57 ASX PGL 57 microRNA therapeutics 57 OTCBB HPLF FWB HL1 57 Inc. Nasdaq INFI 57 Dyax phage display 57 Cintredekin Besudotox 57 Opterone R 57 candidate Zemiva TM 57 class collagenase 57 POSIDUR TM ELADUR TM 57 vinorelbine tartrate 57 fibrotic diseases 57 Inc. OTCBB MIVT 57 deCODE ProstateCancer TM 57 www.nanoviricides.com 57 Innovive Pharmaceuticals 57 Tranzyme 57 Arno Therapeutics 57 Morria Biopharmaceuticals Plc 57 Cleviprex TM clevidipine 57 NEUGENE R 57 Panzem R 57 PDE4 inhibitor 57 treat chronic sinusitis 57 TSX AEZ 57 blood serum biomarkers 57 isoform selective 57 commercialize deforolimus 57 Regado Biosciences 57 Reports Preclinical Data 57 treat gastrointestinal disorders 57 NASDAQ PGNX 57 XmAb ™ 57 molecular chaperone regulation 57 OTCBB IMNR 57 MPH AMEX 57 hypoxia activated prodrug 57 commercializing oxidized glutathione 57 Avian Transgenic Technology 57 autologous cell 57 subsidiary Cira Biosciences 57 OTCBB NPHC biotechnology 57 recombinant biopharmaceutical 57 Brussels THR 57 JAK inhibitors 57 Inc. dba Vitro 57 OTCBB CGXP 57 drugs FUSILEV 56 Biomoda www.biomoda.com 56 DermTech International 56 Therapeutic Competitors companiesandmarkets.com adEgemonye 56 platforms GVAX 56 selective immunoproteasome inhibitor 56 ABL inhibitor 56 targeted anticancer biopharmaceuticals 56 vitreoretinal disorders 56 OncoVex 56 CeNeRx BioPharma 56 Nanobody R 56 aerosolized AAT 56 BC SeraPro ™ 56 Sopherion 56 EPIX Pharmaceuticals Inc. 56 molecular diagnostic assays 56 Captisol ® 56 NASDAQ FLML 56 P2V TM 56 Addrenex 56 Prodarsan ® 56 PORxin TM platforms 56 OGeS 56 Accelerating apoptosis may 56 delivery polymer matrix 56 Ceragenin ™ technology 56 external counterpulsation systems 56 NASDAQ CLDX 56 FoldRx Pharmaceuticals Inc. 56 Exelixis compounds 56 targeted anticancer therapeutics 56 candidate NGX 56 OTCBB ENTB 56 Targeted Chemotherapy 56 cellular immunotherapy 56 vivo fluorescence imaging 56 next generation biobetter 56 AVEO Pharmaceuticals Inc. 56 AB OMXS BINV 56 EOS NASDAQ MELA 56 CD# CEA 56 Inc. OTCBB CADM 56 candidate Trofex TM 56 psoriasis rheumatoid arthritis 56 RNAi therapeutic targeting 56 GeneICE 56 Nanobody ® 56 hypervascular tumors 56 overactive bladder VANTAS R 56 TSX CTI 56 radiation sensitizer 56 Nasdaq PARD biopharmaceutical 56 RECOTHROM R 56 CAMBRIDGE Mass. Alnylam Pharmaceuticals 56 CYT# novel 56 intranasal vaccines derived 56 GTC recombinant human 56 gastro intestinal inflammation 56 novel RNAi therapeutics 56 GVAX ® 56 manufactures minimally invasive 56 NASDAQ ALTH biopharmaceutical 56 topical anti infective 56 OLIGON technology 56 ionotropic glutamate receptor antagonists 56 proprietary biomaterials 56 immuno therapeutic 56 proliferative diseases 56 NYSE AMEX PLX 56 polyneuropathy HIV DSP 56 NYSE Amex YMI 56 Predictive medicine 56 DOS# 56 NASDAQ BMTI 56 BioSilicon TM 56 coagulation disorders 56 BHT DNA 56 Salmedix 56 Smac mimetics 56 commercializing novel biotherapeutics 56 treat refractory angina 56 commercialize MDV# 56 Prism Pharmaceuticals 56 Chemokine Therapeutics 56 Novelos Therapeutics Inc. 56 PRNewswire FirstCall Halozyme Therapeutics 56 NASDAQ INGN 56 prokinetic agent 56 Nasdaq SPPI 56 OTCBB NRGX 56 Cobalamin TM mediated 56 Surfaxin LS 56 Endotis 56 BrachySil TM 56 Phase #b/#a clinical 56 Pharmos pipeline 56 NeuVax 56 small molecule activators 56 therapeutic anticancer 56 Memryte 56 neuropathic pain metabolic diseases 56 Crofelemer budesonide foam 56 multi kinase inhibitor 56 Inc. http:/www.endocare.com 56 novel peptide 56 Photodynamic Therapy PDT 56 TRIST study 56 NASDAQ CLSN 56 Syndax Pharmaceuticals Inc. 56 PINKSHEETS PHMB 56 NASDAQ OPXA 56 AKIP ™ 56 Tissue Repair Company 56 CyDex Pharmaceuticals Inc. 56 Nasdaq ASTM 56 Onalta ™ 56 Droxidopa Chelsea 56 midstage clinical 56 initiated Phase 1b 56 diagnostic assays 56 PROLOR Biotech Inc. 56 QUADRAMET R 56 NP2 Enkephalin 56 Nanobody 56 including thyroiditis RA 56 INOmax R 56 customizable drug eluting 56 doxorubicin Transdrug R 56 Acetylon 56 NASDAQ AVEO 56 hereditary emphysema 56 Quark Biotech Inc. 56 angiotensin analog 56 Spiegelmer ® 56 Tr DNA 56 MOVIPREP R 56 Spiro Rombotis President 56 targeted immunotherapies 56 Myolimus 56 antisense inhibitors 56 optical biosensors 56 eTag assays 56 inflammatory autoimmune diseases 56 systemic RNA interference 56 antiviral therapeutics 56 Archemix Corp. 56 prostate cancer benign prostatic 55 Ampakine compounds 55 Cell TRC 55 Therapeutic Competitors Companies 55 ViOptix 55 Mycograb 55 AMEX ONI 55 leading oral taxane 55 DiaKine 55 therapeutic peptide 55 GVAX cancer 55 Kosmos Pharma 55 AKT inhibitor 55 VIA Pharmaceuticals 55 DermTech 55 Aegerion Pharmaceuticals Inc. 55 diagnostic biomarkers 55 Nasdaq OMER biopharmaceutical 55 HQK 55 Amex KAL 55 developing chemokine 55 Onco TCS 55 pralatrexate injection folate analogue 55 ImmunoCellular Therapeutics Ltd. 55 Inc. NASDAQ AVNR 55 diseases fat malabsorption 55 NYSE Amex RNN 55 CorMedix NYSE Amex 55 Aradigm Corporation 55 Fludara ® 55 PDE4 modulators 55 POTELLIGENT ® 55 Gel repository corticotropin injection 55 novel emulsion formulation 55 Soliris TM eculizumab 55 pharmacological chaperone 55 ocular diseases 55 IL# PE#QQR 55 midstage trials 55 Novolimus 55 visit http:/www.mannkindcorp.com 55 oral salmon calcitonin 55 NurOwn 55 HepDirect 55 Locked Nucleic Acid 55 cosmetic cosmeceutical products 55 miRNA biomarkers 55 EGFR HER 55 ESBA# 55 AMPK activators 55 ORTHOCON 55 Nasdaq ALNY 55 NYSE Amex PTN 55 Nasdaq RXII 55 Fc fusion protein 55 oncology immunology 55 Inc. NASDAQ NBIX 55 VALSTAR TM 55 Nasdaq IDRA 55 topically delivered 55 fibrotic disorders 55 imaging radiopharmaceuticals 55 symbol AVXL 55 proprietary Tissue Repair 55 corticotropin injection 55 investigational monoclonal antibody 55 Angiocept 55 fibrin derived 55 Nicotine Conjugate Vaccine 55 Fibrocell Science 55 metabolically inert oral antifolate 55 diagnostic biomarker 55 Nasdaq HALO 55 Magnetoresistive Random Access 55 Cellerant 55 Alfacell proprietary ribonuclease 55 SoluBest 55 ImmunoGen Inc. 55 YM AIM YMBA 55 Homspera TM 55 omega interferon 55 apomorphine hydrochloride 55 ZFP Therapeutics 55 AVXL 55 incyclinide 55 expanded autologous cellular 55 RTP #i 55 novel peptide therapeutics 55 Quinamed R 55 Endotoxin Activity Assay 55 predictive biomarkers 55 accessories autologous 55 OXIGON TM 55 NeurAxon Inc. 55 ophthalmology dermatology cardiovascular disease 55 ruxolitinib 55 Excellagen 55 Pervasis Therapeutics Inc. 55 eSensor detection technology 55 Awarded Qualifying Therapeutic 55 Company Nasdaq RGDX 55 oxypurinol 55 OTCBB UGNE 55 Cara Therapeutics 55 lintuzumab SGN 55 Nasdaq ENZN 55 OTCBB TDLP 55 CB2 selective 55 OvaRex R 55 neuro inflammatory 55 Levulan ® PDT 55 thetreatment 55 bio therapeutics 55 Submits Response 55 colorectal lung 55 SuperAntibody 55 protein kinase inhibitors 55 Xcytrin R 55 OTCBB URGP specialty 55 Inc. OTCBB OXIS 55 Nasdaq DYAX 55 OTCBB FCSC 55 oral taxane 55 bioadhesive polymer core 55 ATL# [002] 55 Neogenix 55 anticoagulant reversing agent 55 CollaFix ™ 55 Galenea 55 HepeX B 55 Charlesson 55 Etubics 55 POTELLIGENT R 55 NASDAQ PCYC 55 Allovectin 7 55 ZaBeCor 55 PsychoGenics 55 PRNewswire FirstCall Aeterna Zentaris 55 markets HP Acthar 55 Nautilus Biotech 55 TSX VENTURE SVA 55 Soliris eculizumab 55 developing calcitonin 55 Zenvia ™ 55 cervical breast 55 THR beta agonist 55 Onalta TM 55 Cenomed 55 Epiphany Biosciences 55 OTCBB HNAB 55 LensAR 55 RECEPTORS LLC 55 Trophos 55 HuCNS SC ® 55 Nasdaq IDIX 55 OMRIX Biopharmaceuticals Inc. 55 diagnosing infectious diseases 55 NovaBay Aganocide compounds 55 JZP 55 Nasdaq TARG 55 Dynogen 55 Ercole Biotech 55 ASX BNO 55 EHT AGN 55 Nasdaq EPCT 55 therapeutics diagnostics 55 Cardio3KG 55 HP Acthar Gel repository 55 Generx ® 55 tranilast 55 Vipin K. 55 topical formulations 55 AIM OBP 55 GelSite polymer 55 Hybridon 55 PRNewswire FirstCall Neurogen 55 Troxatyl 55 OTCBB IMUC biotechnology 55 Celator 55 TRAIL receptor antibody mapatumumab 55 ZFN TM 55 Applied NeuroSolutions 55 Nasdaq MNKD focused 55 Nuron Biotech 55 aTyr Pharma 55 Ph.D. Targacept 55 Inc. AMEX LIV 55 OMNARIS HFA 55 Idera Pharmaceuticals 55 MGd 55 ImaginAb 55 Prestara TM 55 Kosan dependence 55 Teikoku Pharma USA 55 Elevess 55 targeted antifolate 55 CytoFabTM 55 NASDAQ SNTA biopharmaceutical 55 NASDAQ IMCL 55 PGL# 55 Cerus Corporation 55 sirtuin therapeutics 55 Exagen Diagnostics 55 catalytic antioxidant compounds 55 HepaLife 55 AMEX RGN 55 Cardica Microcutter 55 skeletal muscle contractility 55 Nasdaq NPSP 55 Galderma SA 55 Lisofylline LSF 55 TSX OBP 55 XmAb 55 IND submission 55 NASDAQ CPEX 55 Nasdaq AVNR 55 dexanabinol 55 CYT# potent vascular disrupting 55 PSMA ADC 55 Allovectin 7 r 55 superior bioprocessing 55 DURECT proprietary 55 IV Busulfex 55 JUVISTA R Human 55 Liprotamase 55 ArQule Kinase Inhibitor Platform 55 investigational humanized monoclonal antibody 55 E2F Decoy 55 Nasdaq IMGN biotechnology 55 SYCREST 55 developing Bicifadine serotonin 54 Cx# [002] 54 molecular therapeutics immunotherapies 54 Ipsen Euronext IPN 54 VisEn Medical 54 Nasdaq OMER 54 Alzheimer disease cognitive impairment 54 TÎ ² 4 54 Azedra 54 OTCBB QTXB 54 platinum chemotherapeutic 54 developing TB4 54 Begins Dosing 54 investigational compounds 54 Announces Poster Presentations 54 Harry Palmin President 54 Nasdaq IDRA today 54 neurology immunology 54 Nanotherapeutics 54 NASDAQ LGND 54 deCODE AF TM 54 NASDAQ CYTR biopharmaceutical 54 rxRNA TM compounds 54 successfully commercialize Iluvien 54 Modrenal R 54 Manja Bouman CEO 54 validating biomarkers 54 nitric oxide donating 54 oral gallium 54 OvPlex 54 NASDAQ AVNR 54 ZARS Pharma 54 ghrelin antagonist 54 inhaled prostacyclin 54 vaginally administered lidocaine 54 AlphaRx 54 NASDAQ ABII 54 ProNAi 54 Iris BioTechnologies 54 ALN HPN 54 immunotherapy treatments 54 regenerative stem cell 54 Nasdaq CYTR biopharmaceutical 54 Archexin 54 liposome formulations 54 proprietary radiolabeled monoclonal 54 REGENERX BIOPHARMACEUTICALS INC. 54 Opexa Therapeutics Inc. 54 Bellicum 54 liver resection surgeries 54 monoclonal antibodies MAbs 54 ANAVEX 54 ATL/TV# 54 Delta opioid receptor 54 PhaseBio 54 ALTROPANE R 54 Genaera Corporation 54 adipose derived regenerative 54 Initiates Clinical Trial 54 alpha1 antitrypsin deficiency 54 TYSABRI natalizumab 54 Meritage Pharma 54 IMPAX Laboratories Inc. 54 Inc. www.sanuwave.com 54 CyDex Pharmaceuticals 54 drug ISA# 54 TetraLogic Pharmaceuticals 54 Neuroptix 54 Symphony tCGM 54 BCR ABL inhibitors 54 NasdaqCM PSTI DAX PJT 54 TRIOLEX HE# 54 nanoelectronic detection 54 Affilin ® 54 severe hypercholesterolemia 54 molecular diagnostic tests 54 histamine dihydrochloride 54 aesthetic dermatology 54 ophthalmic diseases 54 Nasdaq EXAS today 54 Bexion 54 neovascular diseases 54 Atrigel 54 PRNewswire FirstCall DURECT Corporation 54 ospemifene 54 ImmunoCellular Therapeutics 54 therapeutics 54 Xytis 54 using VIAdel TM 54 beta secretase inhibitors 54 Nasdaq NRGN 54 AEMD 54 PINK MBLTY 54 HydroFix TM 54 allogeneic cell 54 OTCBB CTIX 54 Aegerion Pharmaceuticals 54 commercialize Aganocide compounds 54 lipoprotein lipase deficiency LPLD 54 Handok Pharmaceuticals 54 NexGenix 54 Celsion Corporation 54 Intellikine 54 PRNewswire FirstCall BioSpecifics Technologies 54 PharmFilm ® 54 AVANIR Pharmaceuticals Inc. 54 Azaya 54 Abbokinase 54 Anaphore 54 Nasdaq SOMX 54 Spectrum Pharmaceuticals acquires 54 myelofibrosis polycythemia vera 54 BEMA TM Fentanyl 54 Nasdaq IMGN 54 Immunicon dependence 54 generation biocompatible coatings 54 plasmid DNA pDNA 54 Inc. NASDAQ BPAX 54 TELINTRA 54 ELADUR ™ 54 dermatological indications 54 Glassia 54 HepaLife Technologies Inc. 54 2A receptor agonist 54 hematological indications 54 AMEX ISV 54 RNA interference RNAi therapeutics 54 TSX ONY 54 cryosurgical treatment 54 biotherapeutics 54 immune modulating drug 54 products MKC# PP 54 Bioral Amphotericin B 54 gallium containing 54 Intraosseous Infusion System 54 Dr. Aiping Young 54 personalized immunotherapy 54 PVCT 54 Pruvel TM 54 epothilones 54 small molecule therapeutics 54 autoimmune indications 54 patented Bioral 54 t2cure GmbH 54 MP4 molecule 54 urethral bulking agent 54 Promedior 54 antibody therapies 54 Inc. NASDAQ AGIX 54 Idun Pharmaceuticals 54 FoldRx 54 volociximab 54 mda 7 54 PRNewswire FirstCall Nastech Pharmaceutical 54 Omeros Corporation 54 DITPA 54 molecular assays 54 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 54 Dicer Substrate Technology 54 MCU cardiovascular 54 Tomophase 54 XNOM 54 IAP inhibitors 54 Selzentry Celsentri 54 Bioaccelerate compounds under 54 INVENT Pharmaceuticals 54 Sirion Therapeutics 54 Cianna Medical Inc. 54 Taligen Therapeutics 54 Ltd. OTCBB IMUC 54 candidates budesonide MMX 54 GEM OS2 54 AngioChem 54 bafetinib 54 NYSE Amex NBY clinical 54 cutaneous T 54 gastrointestinal mucositis 54 PRNewswire FirstCall Kensey Nash 54 Lipid Sciences Inc. 54 Inc. Nasdaq NGEN 54 Genetronics Biomedical Corporation 54 predictive toxicology 54 NASDAQ GNTA 54 PAION AG ISIN 54 Inc. Nasdaq IMGN 54 HCA refiles 54 Exaeris 54 OTC Bulletin Board LWLG 54 gastrointestinal disorders characterized 54 human antibody therapeutics 54 ADVEXIN p# therapy 54 www.sanuwave.com 54 Wafer polifeprosan 54 histone deacetylase inhibitor 54 Inotek Pharmaceuticals Corporation 54 PEGylated interferon 54 BXT # 54 QuantRx Biomedical Corporation 54 syndrome overactive bladder 54 selective angiogenic kinase inhibitor 54 receptor tyrosine kinase inhibitor 54 histone deacetylase HDAC inhibitor 54 NTDDS 54 Nasdaq ANDS 54 iPSC technology 54 sells Osteocel R 54 resorbable biomaterials 54 Fibrin MB 54 Aganocide TM 54 ARIKACE ™ 54 Oncosphere System 54 Nasdaq KERX 54 JAK1 54 IMiDs R 54 vivo pharmacology 54 ActivX 54 Inc. NASDAQ NLTX 54 Inc. Nasdaq IDMI 54 mocetinostat MGCD# 54 novel proprietary KL4 54 INS# [001] 54 barrier gauze dressings 54 KL4 surfactant 54 Adlea TM 54 noninvasive diagnostic 54 rhPDGF BB platform 54 OncoVEX 54 taste modulators 54 DNAi 54 proprietary transdermal 54 Inc. Nasdaq AVRX 54 AAG geldanamycin analog 54 proprietary NexACT ® 54 Panzem 54 PPTI 54 biased ligand 54 OTCBB PVCT 54 Molecular Biometrics 54 Ore Pharmaceuticals 54 Generx TM 54 Nasdaq AEZS 54 Celution TM System 54 Akesis Pharmaceuticals 54 FlowCardia Inc. 54 Infectech 54 Tarmogen 54 anti CD# antibodies 54 PhotoThera 54 antibody fragment therapeutics 54 PRNewswire FirstCall Genta Incorporated 54 product platforms GVAX 54 Viprovex TM 54 Nasdaq FOLD 54 tezampanel NGX# 54 Nasdaq MBRX announced 54 NYSE Amex HEB 54 DELATESTRYL R 54 TRANSDUR ™ 54 AQ4N 54 proprietary intravenous formulation 54 homocysteine assay 54 photodynamic treatment 54 autologous cellular therapies 54 diagnostic prognostic 54 polyclonal antibodies 54 BrachySil ™ 54 Nasdaq ENMD 54 Iluvien ® 54 Inc. AMEX AEN 54 REMOXY R 54 CobaCyte 54 #/#/# Cytokinetics Incorporated 54 ophthalmology dermatology 54 commercializes minimally invasive 54 antibody therapeutics 54 ATD TM gel 54 PDE# inhibitors 54 Vitamin D analogue 54 migraines neurorehabilitation 54 orally administered pharmacological chaperones 54 preclinical compounds 54 Anticalins R 53 Cutanea Life Sciences 53 Nutra Pharma wholly owned 53 Orphan Drug designations 53 Preclinical studies suggest 53 Receptos 53 LungExpress Dx 53 AN# novel 53 OTCBB UGNE http:/www.unigene.com 53 Provecta 53 BARRX Medical Inc. 53 TSX BSY 53 phage display technology 53 Nasdaq PARD 53 Sirius Genomics 53 Adherex Technologies Inc. 53 commercializes oncology 53 Stanate R 53 SMARTICLES ® 53 targeted immunotherapeutics 53 ArQule Kinase Inhibitor 53 Quark Pharmaceuticals 53 RepRegen 53 ProtAffin 53 NUCRYST Pharmaceuticals 53 psoriasis IBD 53 Adherex Technologies 53 TELINTRA R 53 use neuroblocking technology 53 MultiCell Technologies 53 CRMD# 53 NASDAQ CYPB 53 WavSTAT 53 PHX# 53 cardiovascular stents 53 LentiVector technology 53 Nasdaq VRTX 53 hESC derived 53 PRNewswire FirstCall Anesiva 53 Phase lll 53 Inc. OTCBB APNT 53 rheumatoid arthritis thrombocytopenia 53 unique PER.C6 53 FluoroPharma 53 immunotherapeutic vaccine 53 therapeutic peptides 53 metabolite profiling 53 Akela Pharma 53 Ophthotech 53 lucinactant 53 Lauriad 53 fungal infections malaria tuberculosis 53 Pink Sheets CGCP 53 OTCBB OHRP 53 neuronal nicotinic receptors NNRs 53 Nasdaq TGEN 53 delivers sumatriptan 53 Epitomics 53 Xcellerated T Cells 53 regenerative medicine therapies 53 behavioral neurobiology 53 AltheaDx

Back to home page